Age-related sensitivity to endotoxin-induced liver inflammation: Implication of inflammasome/il-1β for steatohepatitis

Aging Cell

Volumn 14, Issue 4, 2015, Pages 524-533

  Chung, Ki Wung ^a   Lee, Eun Kyeong ^a   Kim, Dae Hyun ^a   An, Hye Jin ^a   Kim, Nam Deuk ^a   Im, Dong Soon ^a   Lee, Jaewon ^a   Yu, Byung Pal ^b   Chung, Hae Young ^a  

^a Pusan National University   (South Korea)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Aging; IL 1 ; Inflammasome; Inflammation; Lipid accumulation; LPS

Indexed keywords

ALANINE AMINOTRANSFERASE; INFLAMMASOME; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; LIPOPOLYSACCHARIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

AGE; AGING; ANIMAL; BLOOD; CHEMICALLY INDUCED; FATTY LIVER; GENE EXPRESSION REGULATION; GENETICS; HEP-G2 CELL LINE; HUMAN; IMMUNOLOGY; KUPFFER CELL; LIPID METABOLISM; LIVER; MALE; METABOLISM; PATHOLOGY; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

AGE FACTORS; AGING; ALANINE TRANSAMINASE; ANIMALS; CASPASE 1; FATTY LIVER; GENE EXPRESSION REGULATION; HEP G2 CELLS; HUMANS; INFLAMMASOMES; INTERLEUKIN-1BETA; KUPFFER CELLS; LIPID METABOLISM; LIPOPOLYSACCHARIDES; LIVER; MALE; PPAR ALPHA; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

EID: 84927144715     PISSN: 14749718     EISSN: 14749726     Source Type: Journal    
DOI: 10.1111/acel.12305     Document Type: Article

References (36)

1. Affo S, Morales-Ibanez O, Rodrigo-Torres D, Altamirano J, Blaya D, Dapito DH, Millan C, Coll M, Caviglia JM, Arroyo V, Caballería J, Schwabe RF, Ginès P, Bataller R, Sancho-Bru P (2014) CCL20 mediates lipopolysaccharide induced liver injury and is a potential driver of inflammation and fibrosis in alcoholic hepatitis. Gut 63, 1782–1792.
2. Carre JE, Singer M (2008) Cellular energetic metabolism in sepsis: the need for a systems approach. Biochim. Biophys. Acta 1777, 763–771.
3. Chen X, Zhang C, Zhao M, Shi CE, Zhu RM, Wang H, Zhao H, Wei W, Li JB, Xu DX (2011) Melatonin alleviates lipopolysaccharide-induced hepatic SREBP-1c activation and lipid accumulation in mice. J. Pineal Res. 51, 416–425.
4. Desvergne B, Michalik L, Wahli W (2006) Transcriptional regulation of metabolism. Physiol. Rev. 86, 465–514.
5. Dorshkind K, Montecino-Rodriguez E, Signer RA (2009) The ageing immune system: is it ever too old to become young again? Nat. Rev. Immunol. 9, 57–62.
6. Febbraio MA (2014) Role of interleukins in obesity: implications for metabolic disease. Trends Endocrinol. Metab. 25, 312–319.
7. Feingold KR, Staprans I, Memon RA, Moser AH, Shigenaga JK, Doerrler W, Dinarello CA, Grunfeld C (1992) Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance. J. Lipid Res. 33, 1765–1776.
8. Fontana L, Zhao E, Amir M, Dong H, Tanaka K, Czaja MJ (2013) Aging promotes the development of diet-induced murine steatohepatitis but not steatosis. Hepatology 57, 995–1004.
9. Frith J, Day CP, Henderson E, Burt AD, Newton JL (2009) Non-alcoholic fatty liver disease in older people. Gerontology 55, 607–613.
10. Gershoni JM, Palade GE (1983) Protein blotting: principles and applications. Anal. Biochem. 131, 1–15.
11. Glass CK, Olefsky JM (2012) Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab. 15, 635–645.
12. Gustot T (2011) Multiple organ failure in sepsis: prognosis and role of systemic inflammatory response. Curr. Opin. Crit. Care 17, 153–159.
13. Hardardottir I, Grüunfeld C, Feingold KR (1994) Effects of endotoxin and cytokines on lipid metabolism. Curr. Opin. Lipidol. 5, 207–215.
14. Imaeda AB, Watanabe A, Sohail MA, Mahmood S, Mohamadnejad M, Sutterwala FS, Flavell RA, Mehal WZ (2009) Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome. J. Clin. Invest. 119, 305–314.
15. Kamo N, Ke B, Ghaffari AA, Shen XD, Busuttil RW, Cheng G, Kupiec-Weglinski JW (2013) ASC/caspase-1/IL-1b signaling triggers inflammatory responses by promoting HMGB1 induction in liver ischemia/reperfusion injury. Hepatology 58, 351–362.
16. Kwon HJ, Sung BK, Kim JW, Lee JH, Kim ND, Yoo MA, Kang HS, Baek HS, Bae SJ, Choi JS, Takahashi R, Goto S, Chung HY (2001) The effect of lipopolysaccharide on enhanced inflammatory process with age: modulation of NF-jB. J. Am. Aging Assoc. 4, 163–171.
17. Ma KL, Ruan XZ, Powis SH, Chen Y, Moorhead JF, Varghese Z (2008) Inflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout mice. Hepatology 48, 770–781.
18. Martin GS, Mannino DM, Moss M (2006) The effect of age on the development and outcome of adult sepsis. Crit. Care Med. 34, 15–21.
19. Miele L, Valenza V, La Torre G, Montalto M, Cammarota G, Ricci R, Masciana R, Forgione A, Gabrieli ML, Perotti G, Vecchio FM, Rapaccini G, Gasbarrini G, Day CP, Grieco A (2009) Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology 49, 1877–1887.
20. Miura K, Kodama Y, Inokuchi S, Schnabl B, Aoyama T, Ohnishi H, Olefsky JM, Brenner DA, Seki E (2010) Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice. Gastroenterology 139, 323–334.
21. Negash AA, Ramos HJ, Crochet N, Lau DT, Doehle B, Papic N, Delker DA, Jo J, Bertoletti A, Hagedorn CH, Gale M Jr (2013) IL-1b production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease. PLoS Pathog. 9, e1003330.
22. Nesseler N, Launey Y, Aninat C, Morel F, Malledant Y, Seguin P (2012) Clinical review: the liver in sepsis. Crit. Care 16, 235.
23. Opal SM, Girard TD, Ely EW (2005) The immunopathogenesis of sepsis in elderly patients. Clin. Infect. Dis. 41(Suppl 7), S504–S512.
24. Petrasek J, Dolganiuc A, Csak T, Kurt-Jones EA, Szabo G (2011) Type I interferons protect from Toll-like receptor 9-associated liver injury and regulate IL-1 receptor antagonist in mice. Gastroenterology 140, 697–708.
25. Petrasek J, Bala S, Csak T, Lippai D, Kodys K, Menashy V, Barrieau M, Min SY, Kurt-Jones EA, Szabo G (2012) IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. J. Clin. Invest. 122, 3476–3489.
26. Pinheiro da Silva F, Zampieri FG, Barbeiro DF, Barbeiro HV, Goulart AC, Torggler Filho F, Velasco IT, da Cruz Neto LM, de Souza HP, Machado MC (2013) Septic shock in older people: a prospective cohort study. Immun. Ageing. 10, 21.
27. Rathinam VA, Vanaja SK, Fitzgerald KA (2012) Regulation of inflammasome signaling. Nat. Immunol. 13, 333–342.
28. Reddy JK, Rao MS (2006) Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. Am. J. Physiol. Gastrointest. Liver Physiol. 290, G852–G858.
29. Saito H, Sherwood ER, Varma TK, Evers BM (2003) Effects of aging on mortality, hypothermia, and cytokine induction in mice with endotoxemia or sepsis. Mech. Ageing Dev. 124, 1047–1058.
30. Szabo G, Csak T (2012) Inflammasomes in liver diseases. J. Hepatol. 57, 642–654.
31. Tilg H, Moschen AR (2010) Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 52, 1836–1846.
32. Turnbull IR, Clark AT, Stromberg PE, Dixon DJ, Woolsey CA, Davis CG, Hotchkiss RS, Buchman TG, Coopersmith CM (2009) Effects of aging on the immunopathologic response to sepsis. Crit. Care Med. 37, 1018–1023.
33. Vuppalanchi R, Chalasani N (2009) Non-alcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology 49, 306–317.
34. Wree A, Broderick L, Canbay A, Hoffman HM, Feldstein AE (2013) From NAFLD to NASH to cirrhosis-new insights into disease mechanisms. Nat. Rev. Gastroenterol. Hepatol. 10, 627–636.
35. Wree A, Eguchi A, McGeough MD, Pena CA, Johnson CD, Canbay A, Hoffman HM, Feldstein AE (2014) NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice. Hepatology 59, 898–910.
36. Yecies JL, Zhang HH, Menon S, Liu S, Yecies D, Lipovsky AI, Gorgun C, Kwiatkowski DJ, Hotamisligil GS, Lee CH, Manning BD (2011) Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways. Cell Metab. 14, 21–32.